Metastatic Type II Papillary Renal Cell Carcinoma With Recurrent Complete Responses to Sunitinib: A Case Report With a Literature Review

Papillary renal cell carcinoma (PRCC) is a less common subtype of kidney cancer and is typically more resistant to systemic treatments. This report describes a patient with metastatic type II PRCC who experienced two complete responses (CR) to the tyrosine kinase inhibitor (TKI) sunitinib. The patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Ashour, Bayan H, Azam, Faisal, Ibnshamsah, Fahad, Alrowais, Fahad, Al-Garni, Ayed, Al-Shamsi, Humaid O, Bukhari, Nedal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246320/
https://www.ncbi.nlm.nih.gov/pubmed/35800817
http://dx.doi.org/10.7759/cureus.25541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246320/
https://www.ncbi.nlm.nih.gov/pubmed/35800817
http://dx.doi.org/10.7759/cureus.25541

Ejemplares similares